本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Amneal Pharmaceuticals, Inc.

7.74
+0.08001.04%
盘后7.740.00000.00%19:42 EDT
成交量:315.65万
成交额:2,437.53万
市值:24.26亿
市盈率:-20.46
高:7.85
开:7.63
低:7.48
收:7.66
数据加载中...
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/07

重要事件披露

Form 8-K - Current report
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/28

重要事件披露

Form 8-K - Current report
2025/01/15

重要事件披露

Form 8-K - Current report
2025/01/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/08

重要事件披露

Form 8-K - Current report
2024/10/31

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/01

重要事件披露

Form 8-K - Current report
2024/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities